-
1.Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas 失效
标题翻译: 使用喹啉基,异喹啉基或吡啶基脲来抑制RAF激酶公开(公告)号:US07928239B2
公开(公告)日:2011-04-19
申请号:US09777920
申请日:2001-02-07
申请人: Jacques Dumas , Bernd Riedl , Uday Khire , Jill E. Wood , Robert N. Sibley , Mary-Katherine Monahan , Joel Renick , David E. Gunn , Timothy B. Lowinger , William J. Scott , Roger A. Smith
发明人: Jacques Dumas , Bernd Riedl , Uday Khire , Jill E. Wood , Robert N. Sibley , Mary-Katherine Monahan , Joel Renick , David E. Gunn , Timothy B. Lowinger , William J. Scott , Roger A. Smith
IPC分类号: C07D401/02 , A61K31/44 , A61K31/47
CPC分类号: C07D213/75 , C07C275/28 , C07C275/30 , C07C275/32 , C07C275/36 , C07C275/40 , C07C311/29 , C07C317/22 , C07D209/48 , C07D213/81 , C07D213/82 , C07D215/38 , C07D217/22 , C07D295/13 , C07D295/135 , C07D295/192 , C07D307/14 , C07D401/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗raf介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
2.Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas 审中-公开
标题翻译: 使用喹啉基,异喹啉基或吡啶基脲进行Raf激酶的抑制公开(公告)号:US20080194580A1
公开(公告)日:2008-08-14
申请号:US11932269
申请日:2007-10-31
申请人: Jacques Dumas , Bernd Riedl , Uday Khire , Robert N. Sibley , Holia Hatoum-Mokdad , Mary-Katherine Monahan , David E. Gunn , Timotthy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
发明人: Jacques Dumas , Bernd Riedl , Uday Khire , Robert N. Sibley , Holia Hatoum-Mokdad , Mary-Katherine Monahan , David E. Gunn , Timotthy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
IPC分类号: A61K31/496 , A61K31/444 , A61K31/44 , A61P35/00 , A61K31/47
CPC分类号: C07D213/40
摘要: This invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.
摘要翻译: 本发明涉及一组喹啉基,异喹啉基和吡啶基脲,它们在治疗raf介导的疾病中的用途,以及包含用于这种治疗的这些尿素的药物组合物。
-
公开(公告)号:US20080108672A1
公开(公告)日:2008-05-08
申请号:US11768104
申请日:2007-06-25
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
IPC分类号: A61K31/44 , C07C275/40 , A61P35/00 , C07C275/38
CPC分类号: C07C275/40 , C07C275/30 , C07C275/34 , C07D213/81 , C07D401/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
-
4.
公开(公告)号:US07351834B1
公开(公告)日:2008-04-01
申请号:US09889227
申请日:2000-01-12
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy Lowinger , William Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy Lowinger , William Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
IPC分类号: C07D213/30 , A61K31/44
CPC分类号: C07D209/48 , C07C251/48 , C07C275/28 , C07C275/30 , C07C275/32 , C07C275/36 , C07C275/40 , C07C311/29 , C07C317/22 , C07D207/09 , C07D209/46 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/81 , C07D213/82 , C07D295/12 , C07D295/13 , C07D295/135 , C07D295/18 , C07D295/192 , C07D307/14 , C07D401/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗raf介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
5.omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors 有权
标题翻译: ω-羧基芳基取代的二苯脲作为p38激酶抑制剂公开(公告)号:US20080027061A1
公开(公告)日:2008-01-31
申请号:US11845597
申请日:2007-08-27
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy Lowinger , William Scott , Roger Smith , Jill Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy Lowinger , William Scott , Roger Smith , Jill Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
IPC分类号: A61K31/535 , A61K31/17 , A61P19/02 , A61K31/495
CPC分类号: A61K31/5377 , A61K31/17 , A61K31/18 , A61K31/24 , A61K31/341 , A61K31/40 , A61K31/4035 , A61K31/44 , A61K31/4439 , A61K31/4453 , A61K31/495 , A61K31/496 , A61K31/535 , A61K31/5375 , Y02A50/401 , Y02A50/411 , Y02A50/414 , Y02A50/473
摘要: This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗p38介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
6.Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors 有权
标题翻译: ω-羧基芳基取代的二苯脲作为raf激酶抑制剂公开(公告)号:US07235576B1
公开(公告)日:2007-06-26
申请号:US10042203
申请日:2002-01-11
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
IPC分类号: A61K31/17 , A61K31/44 , C07D213/30 , C07C275/18 , C07C275/34
CPC分类号: C07D209/48 , C07D213/75 , C07D213/81 , C07D401/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗raf介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
7.
公开(公告)号:US07897623B2
公开(公告)日:2011-03-01
申请号:US11845597
申请日:2007-08-27
申请人: Bernd Riedl , Jacques Dumas , Uday R. Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday R. Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
IPC分类号: A61K31/44
CPC分类号: A61K31/5377 , A61K31/17 , A61K31/18 , A61K31/24 , A61K31/341 , A61K31/40 , A61K31/4035 , A61K31/44 , A61K31/4439 , A61K31/4453 , A61K31/495 , A61K31/496 , A61K31/535 , A61K31/5375 , Y02A50/401 , Y02A50/411 , Y02A50/414 , Y02A50/473
摘要: This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗p38介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
8.OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS 审中-公开
标题翻译: OMEGA-CARBOXY ARYL替代二苯醚作为p38激酶抑制剂公开(公告)号:US20090118268A1
公开(公告)日:2009-05-07
申请号:US12249386
申请日:2008-10-10
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
IPC分类号: A61K31/17 , A61K31/4035 , A61K31/4412 , A61K31/5375 , A61K31/495 , A61K31/496 , A61K31/4453 , A61K31/341 , A61K31/40 , A61P35/00 , A61P19/00
CPC分类号: A61K31/5377 , A61K31/17 , A61K31/18 , A61K31/24 , A61K31/341 , A61K31/40 , A61K31/4035 , A61K31/44 , A61K31/4439 , A61K31/4453 , A61K31/495 , A61K31/496 , A61K31/535 , A61K31/5375 , Y02A50/401 , Y02A50/411 , Y02A50/414 , Y02A50/473
摘要: This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗p38介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
9.Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors 审中-公开
标题翻译: ω-羧酰基取代的二苯脲作为Raf激酶抑制剂公开(公告)号:US20080153823A1
公开(公告)日:2008-06-26
申请号:US11956111
申请日:2007-12-13
申请人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
发明人: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert Sibley
IPC分类号: A61K31/5377 , C07D211/70 , C07D209/36 , C07D413/12 , A61K31/44 , A61K31/4965 , A61P43/00 , A61K31/497 , A61K31/4035 , C07D401/12 , C07D241/02
CPC分类号: C07D209/48 , C07C251/48 , C07C275/28 , C07C275/30 , C07C275/32 , C07C275/36 , C07C275/40 , C07C311/29 , C07C317/22 , C07D207/09 , C07D209/46 , C07D213/74 , C07D213/75 , C07D213/79 , C07D213/81 , C07D213/82 , C07D295/12 , C07D295/13 , C07D295/135 , C07D295/18 , C07D295/192 , C07D307/14 , C07D401/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要翻译: 本发明涉及一组芳基脲在治疗raf介导的疾病中的用途,以及用于此类治疗的药物组合物。
-
10.Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas 失效
标题翻译: 使用喹啉基,异喹啉基或吡啶基脲来抑制raf激酶公开(公告)号:US07371763B2
公开(公告)日:2008-05-13
申请号:US11158048
申请日:2005-06-22
申请人: Jacques Dumas , Bernd Riedl , Uday Khire , Robert N. Sibley , Holia Hatoum-Mokdad , Mary-Katherine Monahan , David E. Gunn , Timotthy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
发明人: Jacques Dumas , Bernd Riedl , Uday Khire , Robert N. Sibley , Holia Hatoum-Mokdad , Mary-Katherine Monahan , David E. Gunn , Timotthy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
IPC分类号: C07D401/02 , A61K31/44 , A61K31/47
CPC分类号: C07D213/40
摘要: The invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.
摘要翻译: 本发明涉及一组喹啉基,异喹啉基和吡啶基脲,它们在治疗raf介导的疾病中的用途,以及含有用于这种治疗的这些尿素的药物组合物。
-
-
-
-
-
-
-
-
-